Salivary SARS-CoV-2 Load of Covid-19 Patients After Oral Antimicrobial Solutions and Dentifrices

NACompletedINTERVENTIONAL
Enrollment

202

Participants

Timeline

Start Date

July 14, 2020

Primary Completion Date

December 30, 2020

Study Completion Date

September 30, 2021

Conditions
Corona Virus Infection
Interventions
OTHER

Colgate Periogard® mouthwash

Patients will be submitted to antisepsia of the oral mucosa with Colgate Periogard® mouthwash

OTHER

Colgate Peroxyl® mouthwash

Patients will be submitted to antisepsia of the oral mucosa with Colgate Peroxyl® mouthwash

OTHER

Colgate Total® Mouthwash

Patients will be submitted to antisepsia of the oral mucosa with Colgate Total® Mouthwash

OTHER

Toothpaste with sodium monofluorophosphate

Patients will be submitted to brushing with toothpaste with sodium monofluorophosphate

OTHER

Toothpaste with sodium fluoride and zinc

Patients will be submitted to brushing with toothpaste with sodium fluoride and zinc

OTHER

Toothpaste with tin fluoride

Patients will be submitted to brushing with toothpaste with tin fluoride

Trial Locations (1)

05652-900

Hospital israelita Albert Einstein, São Paulo

All Listed Sponsors
collaborator

Colgate Palmolive

INDUSTRY

lead

Hospital Israelita Albert Einstein

OTHER

NCT04537962 - Salivary SARS-CoV-2 Load of Covid-19 Patients After Oral Antimicrobial Solutions and Dentifrices | Biotech Hunter | Biotech Hunter